Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.
Journal: The Journal of urology
Published: August 29, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
Journal: The New England journal of medicine
Published: February 02, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Journal: European urology
Published: June 03, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.
Journal: Urologic oncology
Published: March 14, 2016
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
Journal: International journal of radiation oncology, biology, physics
Published: August 05, 2015
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 05, 2014
Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder.
Journal: Urologia internationalis
Published: May 06, 2014
Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.
Journal: Current urology reports
Published: January 24, 2013
Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
Journal: International journal of radiation oncology, biology, physics
Published: August 17, 2012
Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases.
Journal: Human pathology
Published: June 29, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026